Detalhe da pesquisa
1.
PD-1/PD-L1 immune checkpoint and p53 loss facilitate tumor progression in activated B-cell diffuse large B-cell lymphomas.
Blood
; 133(22): 2401-2412, 2019 05 30.
Artigo
Inglês
| MEDLINE | ID: mdl-30975638
2.
Targeting the anion exchanger 2 with specific peptides as a new therapeutic approach in B lymphoid neoplasms.
Haematologica
; 103(6): 1065-1072, 2018 06.
Artigo
Inglês
| MEDLINE | ID: mdl-29191842
3.
Preneoplastic somatic mutations including MYD88L265P in lymphoplasmacytic lymphoma.
Sci Adv
; 8(3): eabl4644, 2022 01 21.
Artigo
Inglês
| MEDLINE | ID: mdl-35044826
4.
Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer.
Breast Cancer Res
; 13(1): R11, 2011 Jan 28.
Artigo
Inglês
| MEDLINE | ID: mdl-21276249
5.
The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models.
Nat Commun
; 10(1): 2235, 2019 05 28.
Artigo
Inglês
| MEDLINE | ID: mdl-31138805
6.
Discovery of Reversible DNA Methyltransferase and Lysine Methyltransferase G9a Inhibitors with Antitumoral in Vivo Efficacy.
J Med Chem
; 61(15): 6518-6545, 2018 Aug 09.
Artigo
Inglês
| MEDLINE | ID: mdl-29953809
7.
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs in hematological malignancies.
Nat Commun
; 8: 15424, 2017 05 26.
Artigo
Inglês
| MEDLINE | ID: mdl-28548080
8.
Intrinsic resistance to PIM kinase inhibition in AML through p38α-mediated feedback activation of mTOR signaling.
Oncotarget
; 7(25): 37407-37419, 2016 Jun 21.
Artigo
Inglês
| MEDLINE | ID: mdl-27270648
9.
NH(2)-terminal truncated HER-2 protein but not full-length receptor is associated with nodal metastasis in human breast cancer.
Clin Cancer Res
; 8(2): 347-53, 2002 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-11839648
10.
Ovarian hormones are not required for PRL-induced mammary tumorigenesis, but estrogen enhances neoplastic processes.
J Endocrinol
; 203(1): 99-110, 2009 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-19635758